Richmond Pharmacology is a clinical research organization that designs and delivers early phase clinical trials. It specializes in early phase adaptive studies (including first-in-human), cardiac safety, intensive ECG, and thorough QT studies, ethnic bridging studies, and early phase patient studies (therapeutic and non-therapeutic). The company also offers patient recruitment, regulatory management, bioanalytics, data management, protocol writing, and other services.